Skip to content
Screener

Inogen INGN EPS (Diluted)

EPS (Diluted) at other companies

ResMed Inc. logo
ResMed Inc.RMD
$2.64+2.3%
AdaptHealth logo
AdaptHealthAHCO
-$0.12-140%
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$0.060.0%
Pulmonx Corporation logo
Pulmonx CorporationLUNG
-$0.33+8.3%
Savara logo
SavaraSVRA
-$0.16-14.3%
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
-$0.01+97.7%

Other financials

Income statement

See full
Revenue$95.1M+3.0%
Gross profit$50.1M+2.7%
Operating income-$5.1M+16.9%
Net income-$3.9M+7.3%

Balance sheet

See full
Cash & equivalents$87.3M-15.8%
Total debt$15.8M-17.0%
Total equity$174.9M-12.3%
Total assets$285.6M-8.5%

Cash flow

See full
Operating cash flow-$6.7M+60.2%
CapEx$711.0K+3.9%
Free cash flow-$6.9M+59.6%

Valuation

See full
Market cap$147.55M-31.2%
Enterprise value$76.07M-41.4%
P/S0.4×-0.2×

Profitability

See full
Gross margin52.7%-1.6pp
Operating margin-8.7%-0.7pp
Net margin-6.9%-0.5pp
FCF margin0.4%

Returns & leverage

See full
Return on equity-13.1%-0.3pp
Debt / equity0.1×0.0×
Current ratio2.7×-0.3×

Where this comes from

Reported directly by Inogen in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Inogen’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001294133-26-000034
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Change in net unrealized (losses) gains on marketable securities(11)42642
Total other comprehensive (loss) income, net of tax(339)3,398(1,167)4,388
Comprehensive loss$(4,189)$(754)$(13,341)$(5,938)
Basic net loss per share attributable to common stockholders (Note 6)$(0.14)$(0.15)$(0.45)$(0.40)
Diluted net loss per share attributable to common stockholders (Note 6)$(0.14)$(0.15)$(0.45)$(0.40)
Weighted average number of shares used in calculating net loss per share attributable to common stockholders:
Basic shares of common stock27,045,09526,962,46527,183,00026,068,421
Diluted shares of common stock27,045,09526,962,46527,183,00026,068,421

Item 1. Financial Statements

FAQ

What is Inogen's EPS (diluted)?
Inogen (INGN) reported EPS (diluted) of -$0.14 in Q2 2026.
How has Inogen's EPS (diluted) changed year-over-year?
Inogen's EPS (diluted) increased by 6.7% year-over-year, from -$0.15 to -$0.14.
What is the long-term trend for Inogen's EPS (diluted)?
Over 4 years (2021 to 2025), Inogen's EPS (diluted) has grown at a 31.6% compound annual growth rate (CAGR), from -$0.29 to -$0.87.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Inogen's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude